Dr. Hayle T. Aldren, MD, MD(H)
Dr. Hayle T. Aldren, MD, MD(H), is a consulting physician who has been involved in integrative, occupational-environmental, and rehabilitation oncology since the 1970s, when he first worked in cancer research as a student at Scripps Clinic and Research Foundation. He is among the few dually licensed doctors in both allopathic and homeopathic medicine, and believes in combining the best from both the orthodox/conventional and unorthodox/alternative medical worlds to support chronic disease recovery and cancer survivorship.
He received his MD from Boston University, where he was one of only two students to elect advanced studies in nutrition, and did post-graduate training at the University of Miami, Cornell University Medical Center, the New York Hospital, and Memorial Sloan-Kettering Cancer Center. He is a diplomate in medical acupuncture from UCLA, and a diplomate of the Royal College of Surgeons (Ireland) in tropical medicine and parasitology.
He also studied abroad in Germany and Hong Kong, as well as with extraordinary figures in the field including Emanuel Revici, W. D. Kelley, A. U. Ramakrishnan, Johanna Budwig, Thomas Rau, Dietrich Klinghardt, Michio Kushi, Ann Wigmore, Virginia Livingston, Judah Folkman, Tullio Simoncini, Lawrence LeShan, Bernie Siegel, Elizabeth Kübler-Ross, Tsu-Tsair Chi, Donato Perez Garcia, Rigdon Lentz, Garry Gordon, Burton Berkson, and others including Nobel Prize winners Linus Pauling and Albert Szent-Györgyi.
He was an early adopter in using biological response modifiers, sensitivity assays, hyperthermia, photo/electrolytic and oxidative approaches, metronomic therapies and anti-angiogenics, and was a senior international trainer for ten years. He was formerly a consultant with the Special Cancer Research Project, Life Extension Foundation, and International Strategic Cancer Alliance. His research interests have included reducing side effects and enhancing efficacy with exercise and fasting, reversing the symptoms of chemo-brain and cognitive impairment, and mounting immune responses against targets such as tumors and pathogenic organisms involved in many chronic diseases and failures to heal. Because cancer, like diseases such as Alzheimer’s, behaves as a chronic metabolic and inflammatory disorder, with associated onco-genetic instability, combining different modes of treatment can lead to therapeutic synergy with decreased toxicity.
